| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2012 | WO2012006683A1 Pharmaceutical compositions for sustained delivery of benzodiazepine antagonists |
| 01/19/2012 | WO2012006680A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| 01/19/2012 | WO2011153377A3 Methods and compositions for treating a subject for central nervous system (cns) injury |
| 01/19/2012 | WO2011148379A3 Antipsychotic-induced parkinsonism genotypes and methods of using same |
| 01/19/2012 | WO2011146825A3 Avian influenza h5n1 specific aptamers and their use |
| 01/19/2012 | WO2011143503A3 Tetracycline compositions |
| 01/19/2012 | WO2011141708A3 New particles of tetracyclines and protecting agent |
| 01/19/2012 | WO2011141180A8 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 01/19/2012 | WO2011138751A3 Heterocyclic derivatives as alk inhibitors |
| 01/19/2012 | WO2011137160A3 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| 01/19/2012 | WO2011130719A3 A biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs |
| 01/19/2012 | WO2011129936A3 Compositions and methods for the prevention and treatment of cancer |
| 01/19/2012 | WO2011127088A3 Methods and compositions for decreasing chronic pain |
| 01/19/2012 | WO2011126910A3 Compositions and methods for the treatment of somatosensory disorders |
| 01/19/2012 | WO2011117870A3 Compositions for topical administration |
| 01/19/2012 | WO2011117391A3 Novel composition for treatment of essential thrombocythemia |
| 01/19/2012 | WO2011113005A3 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo) |
| 01/19/2012 | WO2011112859A3 Methods relating to olanzapine pharmacogenetics |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011112687A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011112414A3 Compound, composition, and method for protecting skin from high energy visible light |
| 01/19/2012 | WO2011112243A3 Beta -adrenergic receptor agonists and uses thereof |
| 01/19/2012 | WO2011109679A3 Inhibitors of 5-lipoxygenase |
| 01/19/2012 | WO2011109551A3 Compounds that modulate intracellular calcium |
| 01/19/2012 | WO2011109494A3 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 01/19/2012 | WO2011109398A3 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 01/19/2012 | WO2011106650A3 Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| 01/19/2012 | WO2011106573A3 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 01/19/2012 | WO2011106106A3 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 01/19/2012 | WO2011103528A3 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 01/19/2012 | WO2011103289A3 Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| 01/19/2012 | WO2011103123A3 Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
| 01/19/2012 | WO2011102660A3 A novel 5-membered heterocycle derivatives and manufacturing process thereof |
| 01/19/2012 | WO2011102655A3 Composition for percutaneous administration of tolterodine with reduced skin irritation |
| 01/19/2012 | WO2011101863A3 Extended release pharmaceutical compositions of lacosamide |
| 01/19/2012 | WO2011063774A3 Pectin complexes of steroids and pharmaceutical compositions based thereon |
| 01/19/2012 | WO2011060945A3 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases |
| 01/19/2012 | WO2011009852A3 Topical pharmaceutical composition including rel-n- [6 - [ (2r, 6s) - 2, 6 - dimethyl - 4 -morpholinyl] -3 - pyridinyl] - 2 -methyl -41 (trifluoromethoxy) - [1,1' -biphenyl] - 3 - carboxamide |
| 01/19/2012 | WO2011003853A3 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
| 01/19/2012 | WO2010140007A9 Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug |
| 01/19/2012 | WO2010136952A3 Self-microemulsifying mitotane composition |
| 01/19/2012 | WO2010109214A3 A topical parasiticide composition |
| 01/19/2012 | WO2009084034A3 Chromane derivatives as trpv3 modulators |
| 01/19/2012 | US20120017290 Genome editing of a Rosa locus using zinc-finger nucleases |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016289 Articles, compositions, and methods for killing or preventing the growth of microbes |
| 01/19/2012 | US20120016123 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/19/2012 | US20120016118 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 01/19/2012 | US20120016037 Method for prevention and treatment of Alzheimers |
| 01/19/2012 | US20120016036 Material and methods for treating developmental disorders including comorbid and idiopathic autism |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016034 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof |
| 01/19/2012 | US20120016033 Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof |
| 01/19/2012 | US20120016032 Cosmetic Composition Containing Calcium Citrate And N-Acylated Aminoalcohol Derivative To Prevent Dry Skin And Signs Of Cutaneous Ageing |
| 01/19/2012 | US20120016031 Biphenyl compound selective agonists of gamma rar receptors |
| 01/19/2012 | US20120016030 Methoxypolyethylene glycol thioester chelate and uses thereof |
| 01/19/2012 | US20120016029 Antagonists of prostaglandin d2 receptors |
| 01/19/2012 | US20120016028 Method of preparing an unsaturated fatty acid dry concentrate |
| 01/19/2012 | US20120016027 Composition and Method for Improved Lens Comfort |
| 01/19/2012 | US20120016026 Compositions containing non-polar compounds |
| 01/19/2012 | US20120016024 Water-In-Oil Emulsion Composition |
| 01/19/2012 | US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence |
| 01/19/2012 | US20120016021 Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120016019 Pharmaceutical composition for treating or preventing cancer |
| 01/19/2012 | US20120016018 Composition for inducing multiple nuclear division of cells |
| 01/19/2012 | US20120016017 Pharmaceutical composition for treating or preventing cancer |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120016015 Aldehyde conjugated flavonoid preparations |
| 01/19/2012 | US20120016014 Benzothiophene carboxamide compounds, composition and applications thereof |
| 01/19/2012 | US20120016013 Anti-cancer oligodeoxynucleotides |
| 01/19/2012 | US20120016012 RNAi MOLECULE TARGETING THYMIDYLATE SYNTHASE AND APPLICATION THEREOF |
| 01/19/2012 | US20120016011 RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016010 RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016009 Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120016007 Small interference rna complex with increased intracellular transmission capacity |
| 01/19/2012 | US20120016006 Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1 |
| 01/19/2012 | US20120016005 Phagocytic cell delivery of rnai |
| 01/19/2012 | US20120016004 Compositions for inhibiting gene expression and uses thereof |
| 01/19/2012 | US20120016003 Pot1 alternative splicing variants |
| 01/19/2012 | US20120016002 Patient Selection and Therapeutic Methods Using Markers of Prostaglandin Metabolism |
| 01/19/2012 | US20120016001 Succinimide derivatives as ocular hypotensive agents |
| 01/19/2012 | US20120016000 Method to assay phospholipid and triglyceride transfer activity of microsomal triglyceride transfer protein |
| 01/19/2012 | US20120015999 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015997 Pharmaceutical composition for external use |
| 01/19/2012 | US20120015996 Antifungal medicinal compositions |
| 01/19/2012 | US20120015995 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
| 01/19/2012 | US20120015994 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
| 01/19/2012 | US20120015993 Novel Pharmaceutical Forms, and Methods of Making and Using the Same |
| 01/19/2012 | US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015990 Taspase1 inhibitors and their uses |
| 01/19/2012 | US20120015989 Linked myc-max small molecule inhibitors |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015987 Novel polymorph of atazanavir sulfate |
| 01/19/2012 | US20120015986 Salts of dehydroacetic acid as a pyrithione stabilizer in plastics |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |